Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Community Experiences: Real-World Reports Who Tries Microdosing
The titration regimen described in the NEJM 2023 obesity trial (Jastreboff et al.) progressed as follows: Weeks 14 : 2 mg once weekly Weeks 58 : 4 mg once weekly Weeks 912 : 8 mg once weekly Week 12 onwards : Up to 12 mg once weekly (in higher-dose cohorts) This regimen was used exclusively within a regulated clinical trial setting and does not constitute an approved dosing schedule
Nevertheless, grey-market versions of uncertain composition are readily accessible online and "legitimised" through social media marketing
2024;262(1):e230405
however, many existing diagnostic cut-offs were developed in older adults and may not apply to younger populations, highlighting the need for updated studies to validate these tools during treatment with obesity medications [24]
et al., 2025) (Figure 5A)
